Patents | Intellepedia

Idols, Patents and Ganesha- Happy Vinayaka Chavithi!

The post explores how Ganesha idols intersect with patent law and eco-friendly innovations during Ganesh Chaturthi. It highlights inventive methods of idol making and their legal implications in India.

TiVo and Patent Infringement

TiVo has sued Samsung for allegedly infringing four of its multimedia technology patents, targeting both set-top boxes and mobile devices. This litigation highlights TiVo’s ongoing strategy to protect its intellectual property amid evolving market dynamics.

Ericsson has a (i)Ball at the Court

The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found in favour of Ericsson, stressing the importance of prompt patent rights enforcement in India.

Tequila’s Indian Cousin

An Indian food scientist has patented a process to produce tequila-like alcohol from Agave albomarginata, a plant native to the Rayalseema region. The innovation uses the plant’s high-starch pith, yielding a natural, cost-effective spirit called Naturohol.

Pfizer files for Patent on Known Substance

This post examines Pfizer’s patent application on a known substance and the Indian Patent Office’s refusal in light of Section 3d and the Novartis decision. It discusses whether unpublished patent applications can render a substance as “known” and critiques the merging of novelty and subject matter analysis.

Pfizer falls prey to Section 3(d)

This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence of enhanced efficacy in pharmaceutical patent applications.

Working of Patents – A Workable Proposition?

This article critically examines the working of patents in India, focusing on statutory requirements, compulsory licensing, and judicial interpretations. It discusses both commercial and non-commercial working, highlighting the practical complexities faced by patentees under the Indian Patents Act.

Lee Pharma v. AstraZeneca- An unfinished Patent Story

This post examines the Lee Pharma v. AstraZeneca case on compulsory licensing under Indian patent law. The Controller’s decision sheds light on the standards for proving public need, affordable pricing, and working of patents in India.

PIL, IPO and Statement of Working of Patents

This post explores the statutory requirements for the statement of working of patents in India, assessing the legal provisions and practical challenges faced by the patent office. It provides an analytical perspective on compliance, resource implications, and public interest concerns within the Indian patent framework.

Is Statement of Working of Patents For Public Interest?

The post analyses whether the statement of working of patents in India truly advances public interest or remains a procedural formality. It argues that while mandatory, its enforcement does not substantially benefit the public or the innovation ecosystem.